FDA UDI
Not in Commercial Distribution
🇺🇸 United States
Solventum™ Promogran™
DI: 00197998275500
·
Model: M772123V003
·
Solventum US LLC
Product Codes
1
GMDN Terms
1
Identifiers
2
Pkg Device Count
1
Let the assistant research this device
The Research Assistant compiles product codes, classification, clearances and adverse events for this device — and cites every record.
Free to try · every answer cites its records
Basic Information
- Brand Name
- Solventum™ Promogran™
- Primary DI
- 00197998275500
- Version / Model
- M772123V003
- Catalog Number
- M772123V003
- Company Name
- Solventum US LLC
- Labeler DUNS
- 119004140
- Distribution Status
- Not in Commercial Distribution
- Device Count in Pkg
- 1
- Record Status
- Published
- Publish Date
- 2025-09-22
- Public Version
- 2
- Public Version Date
- 2025-10-07
- Public Version Status
- Update
- Public Device Record Key
- a872d0fd-0266-428c-99e2-b77a638a4f7a
- Distribution End Date
- 2025-10-06
Device Description
Solventum™ Promogran™ Collagen Matrix with ORC, M772123, Hexagon, 19.1 in2 (123 cm2), 10/CAR, 4 CAR/CS, 40/CS
Device Characteristics
- Single Use
- Yes
- Prescription Use (Rx)
- Yes
- Over the Counter (OTC)
- No
- Kit
- No
- Combination Product
- No
- HCT/P
- No
- Contains NRL
- No
- Not Made with NRL
- No
- MRI Safety
- Labeling does not contain MRI Safety Information
- Direct Marking Exempt
- Yes
- PM Exempt
- No
- Has Serial Number
- No
- Has Lot/Batch Number
- Yes
- Has Manufacturing Date
- No
- Has Expiration Date
- Yes
- Has Donation ID
- No
Sterilization
- Is Sterile
- Yes
- Sterilization Prior Use
- No
Product Codes
| Code | Name | Medical Specialty | Regulation # | Device Class |
|---|---|---|---|---|
| FRO | Dressing, wound, drug | Unknown | U |
GMDN Terms
| Code | Name | Definition | Implantable | Status |
|---|---|---|---|---|
| 45023 | Animal-derived wound matrix dressing | A bioabsorbable animal-derived protein matrix [e.g., peptides derived from collagen] designed to provide: 1) a matrix of structural proteins and/or 2) a skin template of living cells [fibroblasts], to facilitate the infiltration/attachment of native cells/tissues (e.g., blood vessels) for wound/skin healing. It is available in various forms [e.g., solution, powder, occlusive/semi-occlusive cover (non-oral)] and may include additional compounds (e.g., alginate, fatty acids). It may be intended to be covered with a secondary dressing. It is commonly intended for treating partial- and full-thickness wounds, ulcers, and draining, surgical, and traumatic wounds. This is a single-use device. | No | Active |
Identifiers
| Type | ID | Issuing Agency | Package Type | Qty per Pkg | Pkg Status | Pkg Discontinue Date |
|---|---|---|---|---|---|---|
| Package | 00197998275524 | GS1 | CASE | 40 | Not in Commercial Distribution | 2025-10-06 |
| Primary | 00197998275500 | GS1 |
Customer Contacts
- Phone
- +1(800)228-3957
- [email protected]